NL-OMON53955已完成3 期
A PHASE 3, OPEN-LABEL EXTENSION OF COURAGE-ALS (CY 5031) - CY5032
Cytokinetics0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Able to comprehend and willing to sign an Informed Consent Form (ICF). If the
- •patient is able to comprehend, but non-written consent is given, an impartial
- •witness must sign the ICF form
- •Completed dosing in CY 5031
排除标准
- •Has taken an investigational study drug (other than reldesemtiv) prior to
- •dosing, within 30 days or five half-lives of the prior agent, whichever is
- •When during the study the liver and/or kidney function tests rise to above 3x
- •ULN, the medication intake will be stopped permanently.
研究者
相似试验
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic Lateral Sclerosis (ALS) and who have already participated in clinical study CY 5031.EUCTR2021-004727-33-PTCytokinetics Inc400
招募中
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic Lateral Sclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-ITCYTOKINETICS, INC.400
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic LateralSclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-SECytokinetics Inc400
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic LateralSclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-NLCytokinetics Inc400
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic LateralSclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-DKCytokinetics Inc400